Expert Medical Device Risk Management Consulting Aligned with ISO 14971 & Global Regulatory Standards.
FDAmedix helps MedTech innovators navigate the complexities of ISO 14971, ISO 13485, FDA 21 CFR 820, and EU MDR 2017/745. From design through post-market surveillance, we embed risk management into your product lifecycle—reducing uncertainty, accelerating approvals, and strengthening your regulatory confidence.
Explore Our Risk Management Services
Why Effective Risk Management Is Critical for Medical Device Manufacturers?
The Pressure of Regulatory Compliance: In today’s highly regulated healthcare landscape, medical device manufacturers face mounting pressure to ensure patient safety, regulatory compliance, and product reliability.
The Cost of Oversights: A single oversight in risk management can trigger severe consequences—ranging from costly recalls and reputational damage to regulatory penalties and, most importantly, patient harm.
Risk Management as a Continuous Process: The challenge is compounded by the fact that risk management is not a one‑time activity but a continuous process that must be embedded into every stage of the product lifecycle.
Regulatory Requirements for Risk Management: Standards such as ISO 13485:2016 require documented processes for risk management, while the FDA’s Quality System Regulation (21 CFR Part 820) and Europe’s MDR 2017/745 mandate rigorous oversight of design controls, post‑market surveillance, and risk mitigation.
The Need for Expert Partnership: With global regulatory bodies tightening their expectations, manufacturers need a partner who not only understands the complexities of applying risk management per the ISO 14971:2019 but can also streamline the process for long‑term success.
Your Partner for ISO 14971:2019-Aligned Risk Management Solutions
FDAmedix combines deep regulatory expertise with practical industry experience. We help manufacturers identify, assess, and mitigate risks at every stage of the product lifecycle, from concept and design through production and post‑market monitoring. By tailoring strategies that align with ISO 14971:2019, we reduce operational burdens on your team while ensuring your devices meet the highest standards of safety and compliance.
Driving Superior Compliance, Faster Approvals, and Stronger Market Positioning
Turning Compliance Into a Competitive Edge: FDAmedix stands out by transforming regulatory compliance into a strategic advantage. We implement robust, standards-driven risk management frameworks that not only help you meet regulatory requirements but also enhance product quality, accelerate time-to-market, and strengthen your reputation with regulators, healthcare providers, and patients.
Proven Results in Compliance and Market Positioning: Our clients experience fewer audit findings and smoother regulatory processes. From reduced audit findings under 21 CFR Part 820 to faster CE marking submissions under MDR 2017/745, FDAmedix strengthens your market position in regions that require ISO 13485 certification, ensuring compliance is both efficient and effective.
Enabling Innovation Through Seamless Risk Integration: Beyond compliance, FDAmedix fosters innovation by minimizing uncertainty. Our approach integrates risk management seamlessly into your quality management system, enabling your teams to focus on product development while we handle the complexities of risk mitigation.
Flexible, Global-Ready Risk Management Built for Startups and Industry Leaders Alike
Scalable Solutions for Every Stage of Growth: Whether you’re a startup bringing your first device to market or an established manufacturer managing a complex global portfolio, FDAmedix offers scalable solutions to fit your needs. Our services include risk analysis workshops, documentation support, hazard identification, FMEA facilitation, and the implementation of ongoing monitoring systems that align with ISO 13485’s requirements for continual improvement.
Expert Guidance for Regulatory Compliance and Innovation: We provide expert guidance on integrating risk management into design controls as required by 21 CFR Part 820, and on meeting the EU MDR’s stringent expectations for post-market surveillance. With our support, your team can focus on innovation and growth, while we ensure that your risk management practices remain bulletproof, defensible, and globally compliant.
Safeguard Patient Safety and Drive Business Success with FDAmedix
In a world where patient safety and compliance are non‑negotiable, risk management is not just a regulatory requirement—it is a business imperative and a driver of long‑term success. Partner with FDAmedix to safeguard your devices, protect your reputation, and unlock new opportunities for growth in global markets. With our expertise in ISO 14971, ISO 13485:2016, 21 CFR Part 820, and EU MDR 2017/745, we help you turn risk into resilience and compliance into competitive advantage. Contact us today to learn how we can strengthen your risk management strategy.